Rationale and Evidence for EZH1/2 Inhibitors in PTCL

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
A Discussion With Experts on the Evolving Therapeutic Landscape in T-Cell Lymphomas: Focus on EZH1/2 Inhibitors

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.50
Mechanisms of Action of EZH1 and EZH2 and Anti-EZH1 and EZH2 Therapies

Content Format:

Slideset Download

Credit Type:

--

Credits:

--